Literature DB >> 17510059

Germ line gain of function with SOS1 mutation in hereditary gingival fibromatosis.

Shyh-Ing Jang1, Eun-Jin Lee, P Suzanne Hart, Mukundhan Ramaswami, Debora Pallos, Thomas C Hart.   

Abstract

Mutation of human SOS1 is responsible for hereditary gingival fibromatosis type 1, a benign overgrowth condition of the gingiva. Here, we investigated molecular mechanisms responsible for the increased rate of cell proliferation in gingival fibroblasts caused by mutant SOS1 in vitro. Using ectopic expression of wild-type and mutant SOS1 constructs, we found that truncated SOS1 could localize to the plasma membrane, without growth factor stimuli, leading to sustained activation of Ras/MAPK signaling. Additionally, we observed an increase in the magnitude and duration of ERK signaling in hereditary gingival fibromatosis gingival fibroblasts that was associated with phosphorylation of retinoblastoma tumor suppressor protein and the up-regulation of cell cycle regulators, including cyclins C, D, and E and the E2F/DP transcription factors. These factors promote cell cycle progression from G(1) to S phase, and their up-regulation may underlie the increased gingival fibroblast proliferation observed. Selective depletion of wild-type and mutant SOS1 through small interfering RNA demonstrates the link between mutation of SOS1, ERK signaling, cell proliferation rate, and the expression levels of Egr-1 and proliferating cell nuclear antigen. These findings elucidate the mechanisms for gingival overgrowth mediated by SOS1 gene mutation in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510059     DOI: 10.1074/jbc.M701609200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Copy-number mutations on chromosome 17q24.2-q24.3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasia.

Authors:  Miao Sun; Ning Li; Wu Dong; Zugen Chen; Qing Liu; Yiming Xu; Guang He; Yongyong Shi; Xin Li; Jiajie Hao; Yang Luo; Dandan Shang; Dan Lv; Fen Ma; Dai Zhang; Rui Hua; Chaoxia Lu; Yaran Wen; Lihua Cao; Alan D Irvine; W H Irwin McLean; Qi Dong; Ming-Rong Wang; Jun Yu; Lin He; Wilson H Y Lo; Xue Zhang
Journal:  Am J Hum Genet       Date:  2009-05-21       Impact factor: 11.025

2.  The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.

Authors:  Bruce Korf; Reza Ahmadian; Judith Allanson; Yoko Aoki; Annette Bakker; Emma Burkitt Wright; Brian Denger; Ype Elgersma; Bruce D Gelb; Karen W Gripp; Bronwyn Kerr; Maria Kontaridis; Conxi Lazaro; Corinne Linardic; Reymundo Lozano; Calum A MacRae; Ludwine Messiaen; Sonia Mulero-Navarro; Benjamin Neel; Scott Plotkin; Katherine A Rauen; Amy Roberts; Alcino J Silva; Sitta G Sittampalam; Chao Zhang; Lisa Schoyer
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

3.  SOS1 Gain-of-Function Variants in Dilated Cardiomyopathy.

Authors:  Jason R Cowan; Lorien Salyer; Nathan T Wright; Daniel D Kinnamon; Pedro Amaya; Elizabeth Jordan; Michael J Bamshad; Deborah A Nickerson; Ray E Hershberger
Journal:  Circ Genom Precis Med       Date:  2020-06-30

4.  Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.

Authors:  Chris R Evelyn; Xin Duan; Jacek Biesiada; William L Seibel; Jaroslaw Meller; Yi Zheng
Journal:  Chem Biol       Date:  2014-11-20

5.  Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives.

Authors:  José M Rojas; José Luis Oliva; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

6.  Ras in cancer and developmental diseases.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

Review 7.  Genetic studies of craniofacial anomalies: clinical implications and applications.

Authors:  T C Hart; P S Hart
Journal:  Orthod Craniofac Res       Date:  2009-08       Impact factor: 1.826

8.  Possible pharmacotherapy for nifedipine-induced gingival overgrowth: 18α-glycyrrhetinic acid inhibits human gingival fibroblast growth.

Authors:  R Takeuchi; K Hiratsuka; K Arikawa; M Ono; M Komiya; Y Akimoto; A Fujii; H Matsumoto
Journal:  Br J Pharmacol       Date:  2016-02-03       Impact factor: 8.739

Review 9.  The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Curr Opin Genet Dev       Date:  2009-05-19       Impact factor: 5.578

10.  Refinement of the GINGF3 locus for hereditary gingival fibromatosis.

Authors:  Michael Pampel; Sandra Maier; Alfons Kreczy; Helga Weirich-Schwaiger; Gerd Utermann; Andreas R Janecke
Journal:  Eur J Pediatr       Date:  2009-07-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.